Wound Care startup Okapi Medical recently announced the appointment of new CEO Darren Obrigkeit, Ph.D. Dr. Obrigkeit brings more than 20 years of experience in medical devices and will add to the already experienced Okapi team, joining co-founders Dr. David Kay and William Fuller. Okapi Medical completed their successful studies from August through December 2019,
iData ResearchOkapi Medical Announces New CEO and Successful Clinical Study
During the 2019 American College of Emergency Physicians (ACEP) Scientific Assembly, a Seattle-based medical device company, showcased their expansion of their wound closure products. The microMend, from KitoTech Medical, uses an array of tiny metal staples (microstaples) attached to an adhesive and applies like a bandage. Register to receive a free Wound Care Market Analysis,
iData ResearchKitoTech Medical’s New Wound Closure Products
Register to receive a free Wound Care Market Analysis, Size, Trends | Global | 2019-2025 | MedSuite report synopsis and brochure ZipLine Medical, Inc. announced the recent publication of positive results from two significant clinical studies in two peer-reviewed journals demonstrating that use of Zip® Surgical skin closure leads to better clinical outcomes and healthcare cost savings than do surgical
By Sean Collins, Mikayla Schaffner When good technology is hindered by a lack of reimbursement, and the reimbursement system doesn’t seem to be changing fast enough, you have to find other solutions. That’s exactly what the manufacturers of negative pressure wound therapy (NPWT) devices have had to do in Europe. Negative pressure wound therapy is
iData ResearchPrice Declines Hitting the Negative Pressure Wound Therapy Market in Europe
Register to receive a free US Market Report Suite for Wound Care report synopsis and brochure Baxter International Inc., a major global player in advancing surgical innovation, recently announced that it has received U.S. Food and Drug Administration (FDA) approval for faster preparation of its leading hemostatic product, Floseal Hemostatic Matrix. This new version of Floseal has 20% fewer components
iData ResearchBaxter Unveils the Latest Evolution of Floseal in the Wound Care Market
Register to receive a free US Market Report Suite for Wound and Tissue Management report synopsis and brochure A recently published trial revealed that patients had higher rates of healing when treated for fill-thickness stage III/IV pressure ulcers with OASIS® Wound Matrix and standard of care (SOC) than when using solely SOC. The study showed that the
iData ResearchStudy Shows Cook Biotech’s OASIS® Wound Matrix Exceeds Standard of Care
The total U.S. market for wound care is growing at a rate of 4.6%, which will take the 2018 market value of $10 billion up to $15 billion by 2025. As a result of the large market increase, we decided to outline the top wound care companies in the U.S. and provide some insights on
iData ResearchTop 10 Wound Care Companies in the United States
(Vancouver, British Columbia) – Will diabetic foot ulcer and venous leg ulcer treatment be easier to get in the future? How will manufacturers adjust to the growing demands and unstable future of reimbursement for skin substitutes? These are the types of questions iData Research set out to answer in their latest study on the U.S.
iData ResearchLeg and Foot Ulcer Treatment Could Get Cheaper for Diabetics in the U.S.
Register to receive a free Wound and Tissue Management Market Report Suite 2019 synopsis and brochure Traditionally, surgical wounds have been closed with sutures, staples, Steri-strips, Mastisol, or some combination thereof. There are multiple benefits to using these technologies, but new products are expected to significantly improve the way surgeons close wounds. Ethicon’s Dermabond Prineo mesh and cyanoacrylate-based skin closure systems, as well
iData ResearchNew Wound Closure Technology Set To Triple In Value By 2025, Cannibalize Competitors
Register to receive a free US Market Report Suite for Wound and Tissue Management report synopsis and brochure Stryker announced the acquisition of privately-held HyperBranch Medical Technology, Inc. for a total equity value of approximately $220 million in an all-cash transaction. HyperBranch is dedicated to developing medical devices based on its proprietary polymers and cross-linked hydrogels. Its
iData ResearchStryker Acquires HyperBranch Medical Technology, Inc.